Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-001764-21Phase 2Active
Phase 2, single-arm trial of nicotine in nicotine dependence, sponsored by Magle Group. Primary endpoint: Oral safety and tolerability. Started Apr 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-001764-21.